| |
| |
|
| Insider
Information: |
Tooman Craig A |
| Relationship: |
President and CEO, Dir... |
| City: |
San Antonio |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
160,480 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,653 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
160,480 |
|
|
| Total
Value |
$17,653 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enzon Pharmaceuticals Inc |
ENZN |
Exec VP Finance, CFO |
2010-06-18 |
160,480 |
2005-01-05 |
0 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
President and CEO, Dir... |
2019-07-18 |
0 |
2013-11-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENZN |
Enzon Pharmaceuticals In... |
Exec. VP Finance, CFO |
• – – |
2010-02-24 |
4 |
OE |
$5.73 |
$982,500 |
D/D |
150,000 |
278,096 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2009-05-12 |
4 |
D |
$6.05 |
$9,644 |
D/D |
(1,594) |
125,830 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2009-04-03 |
4 |
S |
$6.12 |
$36,292 |
D/D |
(5,930) |
122,924 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2009-01-17 |
4 |
S |
$6.33 |
$65,237 |
D/D |
(10,306) |
108,806 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2006-03-07 |
4 |
B |
$6.87 |
$6,868 |
D/D |
1,000 |
26,000 |
2.74 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2015-11-09 |
4 |
AS |
$7.52 |
$27,238 |
D/D |
(3,620) |
69,980 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2015-10-02 |
4 |
AS |
$8.06 |
$26,189 |
D/D |
(3,250) |
73,600 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2007-05-11 |
4 |
B |
$8.19 |
$8,190 |
D/D |
1,000 |
52,000 |
2.74 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2010-06-18 |
4 |
OE |
$8.59 |
$1,209,472 |
D/D |
140,800 |
283,580 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2016-09-09 |
4 |
AS |
$9.25 |
$277,599 |
D/D |
(30,000) |
72,424 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec. VP Finance, CFO |
• – – |
2010-02-24 |
4 |
S |
$9.27 |
$1,390,635 |
D/D |
(150,000) |
128,096 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2009-11-23 |
4 |
D |
$10.37 |
$11,023 |
D/D |
(1,063) |
127,767 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec. V.P. Finance, CFO |
• – – |
2010-04-03 |
4 |
D |
$10.48 |
$62,146 |
D/D |
(5,930) |
138,906 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2010-01-05 |
4 |
D |
$10.77 |
$44,771 |
D/D |
(4,157) |
123,610 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2010-01-17 |
4 |
D |
$10.91 |
$103,056 |
D/D |
(9,446) |
114,164 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
• – – |
2010-06-18 |
4 |
S |
$11.25 |
$1,385,220 |
D/D |
(123,100) |
160,480 |
0 |
- |
|
41 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
